Aspirin Bioactivity for Prevention of Cardiovascular Injury in COVID-19
- DOI
- 10.3389/fcvm.2020.562708
- Published
- 2020-11-30
- Container
- Frontiers in Cardiovascular Medicine
- Publisher
- Frontiers Media SA
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3389/fcvm.2020.562708,
title = {Aspirin Bioactivity for Prevention of Cardiovascular Injury in COVID-19},
author = {Temistocles Diaz and Barry H. Trachtenberg and Samuel J. K. Abraham and Rao KosagiSharaf and Armando A. Durant-Archibold},
year = {2020},
journal = {Frontiers in Cardiovascular Medicine},
doi = {10.3389/fcvm.2020.562708},
url = {https://doi.org/10.3389/fcvm.2020.562708}
}RIS
TY - JOUR TI - Aspirin Bioactivity for Prevention of Cardiovascular Injury in COVID-19 AU - Temistocles Diaz AU - Barry H. Trachtenberg AU - Samuel J. K. Abraham AU - Rao KosagiSharaf AU - Armando A. Durant-Archibold PY - 2020 JO - Frontiers in Cardiovascular Medicine DO - 10.3389/fcvm.2020.562708 UR - https://doi.org/10.3389/fcvm.2020.562708 ER -
APA
Diaz, T., Trachtenberg, B. H., Abraham, S. J. K., KosagiSharaf, R., & Durant-Archibold, A. A. (2020). Aspirin Bioactivity for Prevention of Cardiovascular Injury in COVID-19. Frontiers in Cardiovascular Medicine. https://doi.org/10.3389/fcvm.2020.562708
Source records
- crossref · retrieved 2026-09-25T06:38:55.887Z